Anti-IL-5 therapies for asthma-Reference-Cited by-同舟云学术

Anti-IL-5 therapies for asthma

Published:2022-07-12 Issue:7 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Farne Hugo A¹,Wilson Amanda²,Milan Stephen³,Banchoff Emma⁴,Yang Freda⁵,Powell Colin VE⁶

Affiliation:

1. Imperial College; London UK

2. School of Nursing and Midwifery; University of Technology Sydney; Sydney Australia

3. Health Innovation Campus and Centre for Health Futures; Lancaster University; Lancaster UK

4. University of Michigan; Ann Arbor USA

5. Chelsea and Westminster Hospital NHS Foundation Trust; London UK

6. Department of Emergency Medicine; Sidra Medciine; Doha Qatar

Publisher

Wiley

Subject

Pharmacology (medical)

Reference455 articles.

1. Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials;Bernstein;Lancet Respiratory Medicine,2020

2. Study of reslizumab in patients with uncontrolled asthma and elevated blood eosinophils clinicaltrials.gov/show/NCT02452190

3. An efficacy and safety study of reslizumab subcutaneous in patients with oral corticosteroid dependent asthma and elevated blood eosinophils www.clinicaltrials.gov/ct2/show/NCT02501629

4. A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils;Bjermer;European Respiratory Journal,2014

5. Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study;Bjermer;Chest,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of network pharmacology and proteomics to elucidate the mechanism and targets of traditional Chinese medicine Biyuan Tongqiao granule against allergic rhinitis in an ovalbumin-induced mice model;Journal of Ethnopharmacology;2024-01

2. Characteristics and outcomes of patients enrolled in the Connect 360 benralizumab patient support programme in the UK: a retrospective cohort study;BMJ Open Respiratory Research;2024-01

3. 抗IL-5抗体（メポリズマブ）;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2023-12-20

4. Eosinophil Phenotypes Are Functionally Regulated by Resolvin D2 during Allergic Lung Inflammation;American Journal of Respiratory Cell and Molecular Biology;2023-12

5. Refashioning dexpramipexole: A new horizon in eosinophilic asthma?;Journal of Allergy and Clinical Immunology;2023-11